Side Effects of Atropine (SEA) Study

• Status: Completed
• Trial end date: 2019-01-17
• Target enrollment: 0
• Participant gender: All

Summary

This study will perform several objective and subjective measurements of the eye and vision before and after a week of using 0.01% concentration atropine drops. These measurements will help to obtain a comprehensive understanding of the side effects of this concentration of atropine and determine if the drops would be tolerated as a possible preventative treatment for nearsightedness.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jeffrey J. Walline, OD PhD
• Treatments: Atropine

Criteria

Inclusion Criteria:

-N/A

Exclusion Criteria:

• Outside of age range

• History of accommodative (focusing) issues or therapy